IVFCX Fees and Costs — Federated Hermes International Strategic Value Dividend Fund, Class C
Data updated: 2026-07-27
The net expense ratio is 1.95%: a 0.74% management fee, a 0.75% 12b-1 fee plus 0.50% other expenses, less a 0.04% fee waiver. This share class carries a deferred sales charge of up to 1.00%. In fiscal 2025 the fund paid $708K in broker commissions, 0.0953% of average net assets, and portfolio turnover was 32%.
IVFCX Fees and Expenses
Annual operating expenses and sales charges of IVFCX. Prospectus, as of November 30, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.74% |
| 12b-1 fee | 0.75% |
| Other expenses | 0.50% |
| Gross expense ratio | 1.99% |
| Fee waiver | −0.04% |
| Net expense ratio | 1.95% |
| Sales charges | |
|---|---|
| Max front load | 0.00% |
| Max deferred load | 1.00% |
| Redemption fee | 0.00% |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
IVFCX Costs Over Time
On $10,000 invested in IVFCX, assuming 5% a year before costs, total costs come to $1,253 over 5 years, cutting the return by 2.15% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $103 | $0 | $0 |
| Fund expenses (net expense ratio 1.95%) | $205 | $632 | $1,084 |
| Trading costs (broker commissions) | $10 | $31 | $53 |
| Lost growth on money paid in costs | $0 | $33 | $116 |
| Total costs | $318 | $696 | $1,253 |
| Value after costs | $10,182 | $10,880 | $11,510 |
| Impact on return, per year | 3.18% | 2.15% | 2.15% |
IVFCX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending November 30, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.0953%
- Total broker commissions: $708K
- Bought from dealers (principal trades, not a cost): $331.9M
- Portfolio turnover (prospectus): 32%
- Securities lending: none during the year
IVFCX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Instinet, LLC | $229K | 36.35% |
| Liquidnet, Inc. | $101K | 16.07% |
| Jefferies LLC | $79K | 12.51% |
| J.P. Morgan Securities LLC | $55K | 8.65% |
| Merrill Lynch, Pierce, Fenner, & Smith Incorporated | $54K | 8.60% |
| Sanford C. Bernstein & Co., LLC | $36K | 5.68% |
| Barclays Capital Inc. | $32K | 5.13% |
| Berenberg Capital Markets LLC | $17K | 2.67% |
| BNP Paribas Securities Corp. | $15K | 2.31% |
| Goldman Sachs & Co. LLC | $13K | 2.03% |
IVFCX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| Federated Securities Corp | $331.7M | 99.94% |
| BNY Mellon Capital Markets, LLC | $196K | 0.06% |
Federated Hermes International Strategic Value Dividend Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| IVFLX | Class R6 | 0.85% | none |
| IVFIX | Institutional Shares | 0.86% | none |
| IVFAX | Class A | 1.11% | 5.50% |
| IVFCX | Class C | 1.95% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.